{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:39:36Z","timestamp":1792719576529,"version":"4.5.0"},"reference-count":23,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2021]]},"DOI":"10.5761\/atcs.oa.20-00213","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T22:11:53Z","timestamp":1605651113000},"page":"191-199","source":"Crossref","is-referenced-by-count":10,"title":["A Comparative Prospective Observational Study on the Use of Direct Oral Anticoagulants after  Cardiac Surgery for the Management of  Atrial Fibrillation"],"prefix":"10.5761","volume":"27","author":[{"given":"Akira","family":"Sezai","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Taoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Osaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kitazumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keito","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Kamata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018; 39: 1330\u201393.","DOI":"10.1093\/eurheartj\/ehy136"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013)-Digest version. Circ J 2014; 78: 1997\u20132021.","DOI":"10.1253\/circj.CJ-66-0092"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019; 74: 104\u201332.","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883\u201391.","DOI":"10.1056\/NEJMoa1009638"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981\u201392.","DOI":"10.1056\/NEJMoa1107039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093\u2013104.","DOI":"10.1056\/NEJMoa1310907"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sezai A, Shiono M. The role of \u03b2-blockers in cardiac perioperative management. Ann Thorac Cardiovasc Surg 2014; 20: 261\u20136.","DOI":"10.5761\/atcs.ed.13-00374"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sezai A, Osaka S, Yaoita H, et al. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: prevention of atrial fibrillation after cardiac surgery with landiolol hydrochloride for left ventricular dysfunction (PLATON) trial. J Thorac Cardiovasc Surg 2015; 150: 957\u201364.","DOI":"10.1016\/j.jtcvs.2015.07.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Miyairi T, Orimme Y, Matsumiya G, et al. Coronary artery surgery in Japan in 2017. Ann Thorac Cardiovasc Surg 2019; 25: 176\u20138.","DOI":"10.5761\/atcs.sr.18-01000"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sezai A, Nakata K, Iida M, et al. A study on the occurrence and prevention of perioperative stroke after coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 2015; 21: 275\u201381.","DOI":"10.5761\/atcs.oa.15-00089"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sezai A, Osaka S, Yaoita H, et al. Safety of the direct oral anticoagulant edoxaban for atrial fibrillation after cardiac surgery: pilot study. J Atr Fibrillation 2016; 9: 1456.","DOI":"10.4022\/jafib.1456"},{"key":"12","unstructured":"12) Fuster V, Ryd\u00e9n LE, Cannom DS, et al. 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC, 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011; 57: e101\u201398."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630\u20139.","DOI":"10.1161\/CIRCULATIONAHA.112.105221"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Steinberg BA, Peterson ED, Kim S, et al. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation 2015; 131: 488\u201394.","DOI":"10.1161\/CIRCULATIONAHA.114.011777"},{"key":"15","unstructured":"15) Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719\u201347."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Windecker S, Kolh P, Alfonso F, et al. 2014 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014; 35: 2541\u2013619.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Neumann FJ, Sousa-Uva M, Ahlsson A, et al. (2018) ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87\u2013165.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Beller JP, Krebs ED, Hawkins RB, et al. Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing. J Thorac Cardiovasc Surg 2020; 160: 1222\u201331.","DOI":"10.1016\/j.jtcvs.2019.09.064"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Vranckx P, Potpara T, Dagres N, et al. Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey. Europace 2016; 18: 1113\u20136.","DOI":"10.1093\/europace\/euw208"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Yu PJ, Lin D, Catalano M, et al. Impact of novel oral anticoagulants vs warfarin on effusions after coronary artery bypass grafting. J Card Surg 2019; 34: 419\u201323.","DOI":"10.1111\/jocs.14054"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Anderson E, Johnke K, Leedahl D, et al. Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis. Am J Surg 2015; 210: 1095\u2013103.","DOI":"10.1016\/j.amjsurg.2015.07.005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955\u201362.","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Wang KL, Lip GY, Lin SJ, et al. Non-vitamin K antagonist Oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis. Stroke 2015; 46: 2555\u201361.","DOI":"10.1161\/STROKEAHA.115.009947"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/27\/3\/27_oa.20-00213\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:27:48Z","timestamp":1624678068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/27\/3\/27_oa.20-00213\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.20-00213","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}